Ischemic Stroke
Conditions
Interventions
Qizhi Group:Standard medical treatment + Qi-Zhi-Tong-Luo Capsules 4 capsules/time after breakfast and supper + 4 placebo capsules after lunch, for 4 weeks
Naoxintong Group:Standard medical treatment + Naoxintong Capsules 4 capsules tid, for 4 weeks
Sponsors
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 35 to 80 years of age; 2. Symptoms consistent with ischemic stroke in the recovery stage, and without disorders of consciousness; 3. Symptoms consistent with Syndrome of "Qi-deficiency as well as Channel Obstruction by Tan and Blood-Stasis"; 4. Cerebral infarction is 2 weeks to 5 months, and FM score<95 and AQ<93.8; 5. Volunteer subjects, sign the informed consent certificates.
Exclusion criteria
Exclusion criteria: 1. TIA; 2. with cerebral hemorrhage in 6 months; 3. women with gestation or lactation; 4. allergic to the drug or tend to allergy; 5. stroke due to cerebral tumor, cerebral trauma or hematonosis etc. ; 6. stroke due to cerebral embolism; 7. complicated with some serious diseases as liver dysfunction, kidney dysfunction, hematonosisendocrine system diseases(except diabetics); 8. complicated with dysfunction of the joint; 9. complicated with mental disorder; 10. complicated with severe syptoms due to previous cerebral infarction which would influence the evaluation on the effect of this trial; 11. patient who has participated other trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Simplified Fugl-Meyer Assessment after 4 weeks;aphasia quotient after 4 week; | — |
Secondary
| Measure | Time frame |
|---|---|
| Zheng-hou Scales of Stoke after 4 weeks;Assessment of quality of life (QOL) after stroke;incidence of recurrent strok; | — |
Countries
China
Contacts
Public ContactWang Zhong
Outcome results
None listed